Abstract
Purpose
To compare the results of transepithelial photorefractive keratectomy (trans PRK) and brush-assisted photorefractive keratectomy (brush PRK) for the treatment of myopia.
Methods
A total of 146 eyes from 78 patients who received brush PRK or trans PRK with the Schwind Amaris laser platform were included in the present study. Uncorrected distance visual acuity (UDVA) and manifest refraction spherical equivalent (MRSE) at postoperative 1 week, 1, 3, 6, and 12 months were compared between the 2 groups as well as epithelial healing time.
Results
The mean time to complete epithelial healing was 3.27 ± 0.75 days in the trans PRK group and 3.67 ± 0.93 days in the brush PRK group (p < 0.05). At 1 week after surgery, UDVA recovered more rapidly after trans PRK than brush PRK (brush PRK: 0.13 ± 0.12 log MAR units, trans PRK: 0.09 ± 0.08 log MAR units, p < 0.05), however, UDVA was not significantly different at 1, 3, 6, and, 12 months postoperatively between the 2 groups.
References
1. Abad JC, Talamo JH, Vidaurri-Leal J, et al. Dilute ethanol versus mechanical debridement before photorefractive keratectomy. J Cataract Refract Surg. 1996; 22:1427–33.
2. Amoils SP. Photorefractive keratectomy using a scanning-slit laser, rotary epithelial brush, and chilled balanced salt solution. J Cataract Refract Surg. 2000; 26:1596–604.
3. Lee YG, Chen WY, Petroll WM, et al. Corneal haze after photorefractive keratectomy using different epithelial removal techniques: mechanical debridement versus laser scrape. Ophthalmology. 2001; 108:112–20.
4. Pallikaris IG, Naoumidi II, Kalyvianaki MI, Katsanevaki VJ. Epi-LASIK: comparative histological evaluation of mechanical and alcohol-assisted epithelial separation. J Cataract Refract Surg. 2003; 29:1496–501.
5. Lee HK, Lee KS, Kim JK, et al. Epithelial healing and clinical outcomes in excimer laser photorefractive surgery following three epithelial removal techniques: mechanical, alcohol, and excimer laser. Am J Ophthalmol. 2005; 139:56–63.
6. Steinert RF. Wound healing anomalies after excimer laser photorefractive keratectomy: correlation of clinical outcomes, corneal topography, and confocal microscopy. Trans Am Ophthalmol Soc. 1997; 95:629–714.
7. Pallikaris IG, Karoutis AD, Lydataki SE, Siganos DS. Rotating brush for fast removal of corneal epithelium. J Refract Corneal Surg. 1994; 10:439–42.
8. Griffith M, Jackson WB, Lafontaine MD, et al. Evaluation of current techniques of corneal epithelial removal in hyperopic photorefractive keratectomy. J Cataract Refract Surg. 1998; 24:1070–8.
9. Fadlallah A, Fahed D, Khalil K, et al. Transepithelial photorefractive keratectomy: clinical results. J Cataract Refract Surg. 2011; 37:1852–7.
10. Aslanides IM, Padroni S, Arba Mosquera S, et al. Comparison of single-step reverse transepithelial all-surface laser ablation (ASLA) to alcohol-assisted photorefractive keratectomy. Clin Ophthalmol. 2012; 6:973–80.
11. Trokel SL, Srinivasan R, Braren B. Excimer laser surgery of the cornea. Am J Ophthalmol. 1983; 96:710–5.
12. Hersh PS, Brint SF, Maloney RK, et al. Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study. Ophthalmology. 1998; 105:1512–22.
13. Luger MH, Ewering T, Arba-Mosquera S. Consecutive myopia correction with transepithelial versus alcohol-assisted photorefractive keratectomy in contralateral eyes: one-year results. J Cataract Refract Surg. 2012; 38:1414–23.
14. Lee SB, Chung MS. Advanced Surface Ablation-Photorefractive Keratectomy (ASA-PRK): Safety and clinical outcome for the correction of mild to moderate myopia with a thin cornea. J Korean Ophthalmol Soc. 2006; 47:1274–86.
15. Sia RK, Ryan DS, Stutzman RD, et al. Alcohol versus brush PRK: visual outcomes and adverse effects. Lasers Surg Med. 2012; 44:475–81.
16. Kim SY, Sah WJ, Lim YW, Hahn TW. Twenty percent alcohol toxicity on rabbit corneal epithelial cells: electron microscopic study. Cornea. 2002; 21:388–92.
17. Oh JY, Yu JM, Ko JH. Analysis of ethanol effects on corneal epithelium. Invest Ophthalmol Vis Sci. 2013; 54:3852–6.
18. Kanitkar KD, Camp J, Humble H, et al. Pain after epithelial removal by ethanol-assisted mechanical versus transepithelial excimer laser debridement. J Refract Surg. 2000; 16:519–22.
19. Choi JY, Kim HC, Seo KY, et al. Refraction and visual outcome between the enhancement methods on regressed or undercorrected myopia after LASIK. J Korean Ophthalmol Soc. 2006; 47:349–54.
20. Sadeghi HM, Seitz B, Hayashi S, et al. In vitro effects of mitomycin-C on human keratocytes. J Refract Surg. 1998; 14:534–40.
21. Netto MV, Mohan RR, Sinha S, et al. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. J Refract Surg. 2006; 22:562–74.
22. Teus MA, de Benito-Llopis L, Alió JL. Mitomycin C in corneal refractive surgery. Surv Ophthalmol. 2009; 54:487–502.
23. Gambato C, Ghirlando A, Moretto E, et al. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology. 2005; 112:208–18.
24. Rajan MS, O'Brart DP, Patmore A, Marshall J. Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy. J Cataract Refract Surg. 2006; 32:1741–7.
25. Lee DH, Chung HS, Jeon YC, et al. Photorefractive keratectomy with intraoperative mitomycin-C application. J Cataract Refract Surg. 2005; 31:2293–8.
26. Netto MV, Mohan RR, Ambrósio R Jr, et al. Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy. Cornea. 2005; 24:509–22.
Table 1.
Brush PRK | Trans PRK | p-value* | |
---|---|---|---|
Patients (eyes) | 38 (73) | 40 (73) | |
Sex (M/F) | 12/26 | 11/29 | 0.724 |
Age (years) | 26.3 ± 6.8 | 28.3 ± 7.1 | 0.080 |
CDVA (log MAR) | 0.0089 ± 0.0210 | 0.0048 ± 0.0170 | 0.196 |
Sphere (diopter) | −5.34 ± 1.49 | −5.05 ± 1.25 | 0.208 |
Cylinder (diopter) | −1.02 ± 0.58 | −0.84 ± 0.63 | 0.061 |
SE (diopter) | −5.85 ± 1.55 | −5.46 ± 1.31 | 0.109 |
Central corneal thickness (μm) | 539 ± 30 | 536 ± 28 | 0.480 |
Mitomycin C use | 36 (49%) | 33 (45%) | 0.622 |
Table 2.
Brush PRK | Trans PRK | p-value | |
---|---|---|---|
Epithelial healing time (days) | 3.67 ± 0.93 | 3.27 ± 0.75 | 0.005* |
SE (diopter) | |||
1 week | 0.1528 ± 0.5403 | 0.1069 ± 0.5408 | 0.615 |
1 month | −0.0522 ± 0.6851 | 0.0538 ± 0.6335 | 0.345 |
3 months | −0.1033 ± 0.6124 | −0.0299 ± 0.5080 | 0.449 |
6 months | −0.2687 ± 0.7529 | −0.1557 ± 0.5355 | 0.334 |
1 year | −0.3082 ± 0.5493 | −0.1370 ± 0.6223 | 0.080 |
Table 3.
Brush PRK | Trans PRK | p-value | |
---|---|---|---|
1 week | 0.1312 ± 0.1200 | 0.0899 ± 0.0775 | 0.017* |
1 month | 0.0761 ± 0.1689 | 0.0451 ± 0.0538 | 0.142 |
3 months | 0.0203 ± 0.0396 | 0.0231 ± 0.0438 | 0.692 |
6 months | 0.0261 ± 0.0624 | 0.0115 ± 0.0334 | 0.105 |
12 months | 0.0063 ± 0.0188 | 0.0034 ± 0.0127 | 0.276 |
Table 4.
Brush PRK | Trans PRK | p-value | |
---|---|---|---|
Mitomycin C use | 36 (49%) | 33 (45%) | 0.622 |
Epithelial healing time (days) | 3.50 ± 0.08 | 3.14 ± 0.08 | 0.002* |
UDVA (log MAR) | |||
1 week | 0.123 ± 0.014 | 0.098 ± 0.013 | 0.253 |
1 month | 0.050 ± 0.008 | 0.046 ± 0.008 | 0.037* |
3 months | 0.019 ± 0.005 | 0.023 ± 0.005 | 0.230 |
6 months | 0.018 ± 0.005 | 0.012 ± 0.005 | 0.248 |
12 months | 0.006 ± 0.002 | 0.003 ± 0.002 | 0.394 |
SE (diopter) | |||
1 week | 0.172 ± 0.075 | 0.127 ± 0.074 | 0.085 |
1 month | −0.051 ± 0.092 | 0.016 ± 0.091 | 0.382 |
3 months | −0.119 ± 0.079 | −0.064 ± 0.077 | 0.554 |
6 months | −0.216 ± 0.088 | −0.178 ± 0.087 | 0.487 |
12 months | −0.228 ± 0.074 | −0.188 ± 0.073 | 0.912 |